Here's what we know so far for HIV PrEP - The s
Post# of 148268
Quote:
The study evaluated the impact of a macaque-equivalent dose of either 350 mg (once weekly) or 700 mg (bi-monthly) leronlimab on acquisition of infection in a total of 18 animals, and found that the equivalent 700 mg bi-monthly leronlimab dose completely prevented rectal transmission of Simian-Human Immunodeficiency Virus (SHIV) in macaques.
https://www.firstwordpharma.com/node/1738609
I wonder how far along they are on injections every 3 months.
Quote:
Oregon Health & Science University is leading the five-year, $3-million study to explore if a new formulation of the drug leronlimab can prevent infection of the monkey version of HIV in rhesus macaques. If the new formulas work, the injectable drug could potentially be taken every three months instead of weekly, as is recommended with the drug’s current design.
https://news.ohsu.edu/2020/08/04/new-injectio...n-primates